|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2000-1-4
|
|
pubmed:abstractText |
Capillary leakage of sodium-fluorescein (NaF) in the skin reflects capillary permeability and may be a marker of diabetes-associated microcirculatory abnormalities.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0014-2972
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1035-40
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10583451-Albuminuria,
pubmed-meshheading:10583451-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:10583451-Blood Glucose,
pubmed-meshheading:10583451-Capillary Permeability,
pubmed-meshheading:10583451-Diabetes Mellitus, Type 1,
pubmed-meshheading:10583451-Enalapril,
pubmed-meshheading:10583451-Fluorescein,
pubmed-meshheading:10583451-Humans,
pubmed-meshheading:10583451-Microcirculation,
pubmed-meshheading:10583451-Middle Aged,
pubmed-meshheading:10583451-Skin
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Capillary permeability is increased in normo- and microalbuminuric type 1 diabetic patients: amelioration by ACE-inhibition.
|
|
pubmed:affiliation |
Department of General Internal Medicine, University Hospital Groningen,the Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
